Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer

Carcinogenesis

Volumn 23, Issue 2, 2002, Pages 257-264

  Wang, Lizhong ^a   Habuchi, Tomonori ^a   Takahashi, Takeshi ^b   Mitsumori, Kenji ^a   Kamoto, Toshiyuki ^b   Kakehi, Yoshiyuki ^b   Kakinuma, Hideaki ^a   Sato, Kazunari ^a   Nakamura, Akira ^a   Ogawa, Osamu ^b   Kato, Tetsuro ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYCLIN D1; GUANINE; MESSENGER RNA;

ADULT; AGED; ALLELE; ALTERNATIVE RNA SPLICING; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HEALTH STATUS; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSITIONAL CELL CARCINOMA;

EID: 0036121514     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.2.257     Document Type: Article

References (34)

1. Molecular biology of bladder cancer
2. Genetic alterations and biological pathways in human bladder cancer pathogenesis
3. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
4. Deletion of the p16 and p15 genes in human bladder tumors
5. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer
6. Accumulated allelic losses in the development of invasive urothelial cancer
7. Allelotype of human bladder cancer
8. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression
9. Cancer cell cycles
10. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
11. Amplification at chromosome 11q13 in transitional cell tumours of the bladder
12. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification
13. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features
14. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes and cell proliferation
15. Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers
16. Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression of proliferative activity, in transitional cell carcinoma of the bladder
17. Alternate splicing produces a novel cyclin D1 transcript
18. Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner
19. Cyclin D1 (PRAD1) alternative transcript b: Full-length cDNA cloning and expression in breast cancers
20. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck
21. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer
22. Cyclin D1, glutathione S-transferase and cytochrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: Assessment of the importance of individual genes using multivariate analysis
23. Prognostic significance of cyclin D1 gene (CCND1) polymorphism in epithelial ovarian cancer
24. Risk of bladder cancer by source and type of tobacco exposure: A case-control study
25. Drinking, micturition habits and urine concentration as potential risk factors in urinary bladder cancer
26. Histological typing of urinary bladder tumors
27. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction
28. Increased DNA methyltransferase expression in rhabdomyosarcomas
29. Cyclin D1 protein expression and gene polymorphism in colorectal cancer
30. Absence of cyclin D1/PRAD1 point mutations in human breast cancers and parathyroid adenomas and identification of a new cyclin D1 gene polymorphism
31. Alpha-naphthylamine and beta-naphthylamine in cigarette smoke
32. Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis